ID

17835

Descrizione

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Pharmacogenetic and Pharmacogenomic Research.

Keywords

versioni (2)
  1. 04/10/16 04/10/16 -
  2. 05/12/16 05/12/16 -
Caricato su

4 ottobre 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

Inglese

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 moduli  
General Information
Descrizione

General Information

Protocol Identifier: AVA100193
Descrizione

Protocol Identifier

Tipo di dati

boolean

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

integer

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Descrizione

PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research

Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
Descrizione

Informed Consent

Tipo di dati

boolean

If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
Descrizione

Date

Tipo di dati

date

If no, select one reason
Descrizione

Reason for not obtaining informed consent

Tipo di dati

text

If Other, please specify
Descrizione

Specification of Other

Tipo di dati

text

Blood sample collection (DNA)
Descrizione

Blood sample collection (DNA)

Has a blood sample been collected for PGx-pharmacogenetic research?
Descrizione

Has a blood sample been collected for PGx-pharmacogenetic research?

Tipo di dati

boolean

If yes, record the date samples taken.
Descrizione

Date

Tipo di dati

date

Withdrawal of consent
Descrizione

Withdrawal of consent

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Descrizione

Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?

Tipo di dati

boolean

Blood sample Destruction
Descrizione

Blood sample Destruction

Has a request been made for sample destruction?
Descrizione

Has a request been made for sample destruction?

Tipo di dati

boolean

If yes, specify reason
Descrizione

If yes, specify reason

Tipo di dati

text

If other, please specify
Descrizione

Other

Tipo di dati

text

Alias
UMLS CUI [1]
C0205394
Ritorna all'inizio della pagina

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Item Group
PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Informed Consent
Item
Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
boolean
Date
Item
If yes, record the date informed consent obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
date
Item
If no, select one reason
text
Reason for not obtaining informed consent
Code List
If no, select one reason
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator  (2)
CL Item
Other (specify) (3)
Specification of Other
Item
If Other, please specify
text
Item Group
Blood sample collection (DNA)
Has a blood sample been collected for PGx-pharmacogenetic research?
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
Date
Item
If yes, record the date samples taken.
date
Item Group
Withdrawal of consent
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
Item
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
boolean
Item Group
Blood sample Destruction
Has a request been made for sample destruction?
Item
Has a request been made for sample destruction?
boolean
Item
If yes, specify reason
text
If yes, specify reason
Code List
If yes, specify reason
CL Item
Subject requested (1)
CL Item
Other (specify) (2)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial